Network Pharmacology Was Applied to Explore the Mechanism of Remimazolam Applied in General Anesthesia for Gynecological Surgeries

ConditionGynecological Disease

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-64

SponsorSecond Hospital of Shanxi Medical University

About this trial

To explore the related mechanisms by which remimazolam regulates hemodynamic stability, inflammatory factors and the immune system in patients undergoing general anesthesia for gynecological surgeries.

Eligibility criteria

Qualifiers

The patient or their family members sign the informed consent form

Age: 18-64 years old, BMI: 18-30kg/m2

ASA Grade Ⅰ or Ⅱ

Patients undergoing gynecological surgeries (laparoscopic total hysterectomy, adnexectomy and myomectomy)

Disqualifiers

People who are allergic to remimazolam or benzodiazepinesThyroid disease

Long-term use of benzodiazepines

Pregnancy or lactation

Have a history of drug abuse or alcoholism

Trial design

Treatments tested in this trial

Remimazolam
propofol

Treatment groups

40 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Second Hospital of Shanxi Medical University

Lead sponsor

Source ClinicalTrials.gov